Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash & Current Investments (2018 - 2026)

Outset Medical has reported Cash & Current Investments over the past 8 years, most recently at $306.7 million for Q4 2025.

  • Quarterly Cash & Current Investments rose 93.3% to $306.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $306.7 million through Dec 2025, up 93.3% year-over-year, with the annual reading at $306.7 million for FY2025, 93.3% up from the prior year.
  • Cash & Current Investments was $306.7 million for Q4 2025 at Outset Medical, up from $178.6 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $440.4 million in Q1 2022 and troughed at $158.7 million in Q4 2024.
  • The 5-year median for Cash & Current Investments is $239.7 million (2023), against an average of $262.7 million.
  • Year-over-year, Cash & Current Investments skyrocketed 179.27% in 2021 and then tumbled 43.41% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $372.8 million in 2021, then dropped by 21.99% to $290.8 million in 2022, then dropped by 28.94% to $206.7 million in 2023, then dropped by 23.21% to $158.7 million in 2024, then soared by 93.3% to $306.7 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Cash & Current Investments are $306.7 million (Q4 2025), $178.6 million (Q3 2025), and $184.1 million (Q2 2025).